Inflammation News and Research

RSS

Association between long-term air pollution exposure and the early stages of atherosclerosis

Air pollution may trigger and accelerate narrowing of carotid arteries, according to a study presented at the American Heart Association's Scientific Sessions 2004.

8 Nov 2004

Remicade (infliximab) is able to reverse the symptoms of rheumatoid arthritis

A new study published today in Arthritis & Rheumatism demonstrates that Remicade (infliximab) is able to reverse the symptoms of the debilitating disease rheumatoid arthritis (RA) in patients who are newly diagnosed.

5 Nov 2004

Celebrex may one day be used to prevent and even treat breast tumors

The anti-inflammatory drug Celebrex, or celecoxib, reduces tumor mass by encouraging cell death and discouraging both cell proliferation and the sprouting of new blood vessels that feed growing tumors, according to a study reported in the November issue of Molecular Cancer Research.

5 Nov 2004

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

Psoriasis trial enters final stage

Solbec Pharmaceuticals Ltd today announced the successful completion of the first two stages of the Phase I clinical trial of its lead compound, CoramsineTM (SBP002), for the treatment of psoriasis.

4 Nov 2004

Study reveals anti-arthritic effects of bee venom

Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.

4 Nov 2004

Analysis shows Remicade reduces pain associated with Crohn's disease

According to a new sub-analysis from the ACCENT I (A Crohn's disease Clinical trial Evaluating infliximab in a New long-term Treatment regimen) trial patients who received a three-dose induction regimen of Remicade experienced a significantly greater reduction in pain as assessed by four different pain questions after ten weeks, compared with patients who received a single dose of Remicade.

2 Nov 2004

Possible treatment for the fatal lung disease idiopathic pulmonary fibrosis

They found that the anti-cancer drug imatinib mesylate — commercially known as Gleevec and produced by Novartis Pharmaceuticals — can target a gene critical to controlling the disease process. Previously, there had been no treatment and patients usually did not survive beyond three years of diagnosis. Now the treatment is undergoing clinical trials at Mayo Clinic.

2 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004

Gene found to defend against environmental pollutants and pulmonary emphysema

Researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions have identified a “master gene” in mice that controls the action of 50 other genes whose products protect the lungs against environmental pollutants.

1 Nov 2004

New treatment option for patients who have moderately active ulcerative colitis

Results of a study presented today by a Mayo Clinic physician at the 69th Annual Scientific Meeting of the American College of Gastroenterology (ACG) in Orlando, Fla., offer a new treatment option for patients who have moderately active ulcerative colitis.

1 Nov 2004

Red wine delivered though an aerosol for COPD, asthma, and possibly even arthritis

Homing in on mechanisms for the reported effectiveness of resveratrol, which is found in red wine, researchers at Imperial College London, England, confirmed its broad anti-inflammatory action, and found potential for applications in chronic obstructive pulmonary disease (COPD), asthma, and possibly even arthritis.

29 Oct 2004

Study supports earlier findings, and even showed a significantly higher prevalence of periodontal diseases in cardiac patients

Research is racing to help healthcare professionals further understand how periodontal diseases are linked to cardiovascular disease.

28 Oct 2004

Study suggests safer immunization approach to Alzheimer's

Researchers at the University of Illinois at Chicago have had preliminary success with a method of immunization intended to dissolve the plaques in brain tissue that are associated with Alzheimer's disease.

28 Oct 2004

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Combination treatment using the monoclonal antibody cetuximab, along with high dose radiotherapy in the treatment of patients with loco-regionally advanced squamous cell carcinoma of the head and neck results in significant improvements in both loco-regional control and overall survival, according to Dr Jordi Giralt of Val d'Hebron University Hospital.

26 Oct 2004

Inflammation News and Research

Association between long-term air pollution exposure and the early stages of atherosclerosis

Remicade (infliximab) is able to reverse the symptoms of rheumatoid arthritis

Celebrex may one day be used to prevent and even treat breast tumors

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Psoriasis trial enters final stage

Study reveals anti-arthritic effects of bee venom

Analysis shows Remicade reduces pain associated with Crohn's disease

Possible treatment for the fatal lung disease idiopathic pulmonary fibrosis

$73 million to tackle infectious diseases such as West Nile virus and influenza

Gene found to defend against environmental pollutants and pulmonary emphysema

New treatment option for patients who have moderately active ulcerative colitis

Red wine delivered though an aerosol for COPD, asthma, and possibly even arthritis

Study supports earlier findings, and even showed a significantly higher prevalence of periodontal diseases in cardiac patients

Study suggests safer immunization approach to Alzheimer's

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Fish oil reverses age-related ailments

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

Genetic research offers insight into Sjögren's syndrome and the general developmental machinery of the immune system

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News